These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31312806)

  • 1. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).
    Mothe B; Manzardo C; Sanchez-Bernabeu A; Coll P; Morón-López S; Puertas MC; Rosas-Umbert M; Cobarsi P; Escrig R; Perez-Alvarez N; Ruiz I; Rovira C; Meulbroek M; Crook A; Borthwick N; Wee EG; Yang H; Miró JM; Dorrell L; Clotet B; Martinez-Picado J; Brander C; Hanke T
    EClinicalMedicine; 2019; 11():65-80. PubMed ID: 31312806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects.
    Hancock G; Morón-López S; Kopycinski J; Puertas MC; Giannoulatou E; Rose A; Salgado M; Hayton EJ; Crook A; Morgan C; Angus B; Chen F; Yang H; Martinez-Picado J; Hanke T; Dorrell L
    J Int AIDS Soc; 2017 May; 20(1):21171. PubMed ID: 28537062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.
    Hayton EJ; Rose A; Ibrahimsa U; Del Sorbo M; Capone S; Crook A; Black AP; Dorrell L; Hanke T
    PLoS One; 2014; 9(7):e101591. PubMed ID: 25007091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials.
    Hanke T
    Expert Rev Vaccines; 2019 Oct; 18(10):1029-1041. PubMed ID: 31613649
    [No Abstract]   [Full Text] [Related]  

  • 5. Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques.
    Rosario M; Borthwick N; Stewart-Jones GB; Mbewe-Mvula A; Bridgeman A; Colloca S; Montefiori D; McMichael AJ; Nicosia A; Quakkelaar ED; Drijfhout JW; Melief CJ; Hanke T
    AIDS; 2012 Jan; 26(3):275-84. PubMed ID: 22095198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.
    Hartnell F; Brown A; Capone S; Kopycinski J; Bliss C; Makvandi-Nejad S; Swadling L; Ghaffari E; Cicconi P; Del Sorbo M; Sbrocchi R; Esposito I; Vassilev V; Marriott P; Gardiner CM; Bannan C; Bergin C; Hoffmann M; Turner B; Nicosia A; Folgori A; Hanke T; Barnes E; Dorrell L
    Front Immunol; 2018; 9():3175. PubMed ID: 30713538
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.
    Moyo N; Borthwick NJ; Wee EG; Capucci S; Crook A; Dorrell L; Hanke T
    PLoS One; 2017; 12(7):e0181382. PubMed ID: 28719652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
    Ondondo B; Brennan C; Nicosia A; Crome SJ; Hanke T
    Vaccine; 2013 Nov; 31(47):5594-601. PubMed ID: 23831324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
    Bauer A; Podola L; Mann P; Missanga M; Haule A; Sudi L; Nilsson C; Kaluwa B; Lueer C; Mwakatima M; Munseri PJ; Maboko L; Robb ML; Tovanabutra S; Kijak G; Marovich M; McCormack S; Joseph S; Lyamuya E; Wahren B; Sandström E; Biberfeld G; Hoelscher M; Bakari M; Kroidl A; Geldmacher C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28701395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
    Mutua G; Farah B; Langat R; Indangasi J; Ogola S; Onsembe B; Kopycinski JT; Hayes P; Borthwick NJ; Ashraf A; Dally L; Barin B; Tillander A; Gilmour J; De Bont J; Crook A; Hannaman D; Cox JH; Anzala O; Fast PE; Reilly M; Chinyenze K; Jaoko W; Hanke T; Hiv-Core 004 Study Group T
    Mol Ther Methods Clin Dev; 2016; 3():16061. PubMed ID: 27617268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.
    Knudsen ML; Mbewe-Mvula A; Rosario M; Johansson DX; Kakoulidou M; Bridgeman A; Reyes-Sandoval A; Nicosia A; Ljungberg K; Hanke T; Liljeström P
    J Virol; 2012 Apr; 86(8):4082-90. PubMed ID: 22318135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
    Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
    J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice.
    Ondondo B; Abdul-Jawad S; Bridgeman A; Hanke T
    Clin Vaccine Immunol; 2014 Nov; 21(11):1565-72. PubMed ID: 25230940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes.
    Ahmed T; Borthwick NJ; Gilmour J; Hayes P; Dorrell L; Hanke T
    Vaccine; 2016 Feb; 34(9):1215-24. PubMed ID: 26784683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques.
    Borthwick NJ; Rosario M; Schiffner T; Bowles E; Ahmed T; Liljeström P; Stewart-Jones GE; Drijfhout JW; Melief CJ; Hanke T
    Immun Inflamm Dis; 2015 Jun; 3(2):82-93. PubMed ID: 26029368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
    Lévy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Lelièvre JD; Thiébaut R
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
    Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
    de Jong W; Aerts J; Allard S; Brander C; Buyze J; Florence E; van Gorp E; Vanham G; Leal L; Mothe B; Thielemans K; Plana M; Garcia F; Gruters R;
    Trials; 2019 Jun; 20(1):361. PubMed ID: 31208472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
    Fidler S; Stöhr W; Pace M; Dorrell L; Lever A; Pett S; Kinloch-de Loes S; Fox J; Clarke A; Nelson M; Thornhill J; Khan M; Fun A; Bandara M; Kelly D; Kopycinski J; Hanke T; Yang H; Bennett R; Johnson M; Howell B; Barnard R; Wu G; Kaye S; Wills M; Babiker A; Frater J;
    Lancet; 2020 Mar; 395(10227):888-898. PubMed ID: 32085823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
    Mothe B; Hu X; Llano A; Rosati M; Olvera A; Kulkarni V; Valentin A; Alicea C; Pilkington GR; Sardesai NY; Rocafort M; Crespo M; Carrillo J; Marco A; Mullins JI; Dorrell L; Hanke T; Clotet B; Pavlakis GN; Felber BK; Brander C
    J Transl Med; 2015 Feb; 13():60. PubMed ID: 25879820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.